Requip and Halcion drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Requip (ropinirole hydrochloride) and Halcion (triazolam). Common drug interactions include intervertebral disc protrusion among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Requip and Halcion. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

What is Halcion?

Halcion has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 8,268 Halcion users. Check the latest studies of Halcion.



On Jul, 26, 2026

24 people who take Requip and Halcion together, and have interactions are studied.

Requip and Halcion drug interactions.

What are the common drug interactions of Requip and Halcion, by gender? *:

female:

  1. Intervertebral disc protrusion (spinal disc protrusion)
  2. Intestinal obstruction
  3. Irritable bowel syndrome
  4. Left ventricular dysfunction
  5. Ligament sprain (ligament stretched)
  6. Lipoma (a growth of fatty tissue that slowly develops just under your skin)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)
  9. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  10. Migraine (headache)

male:

  1. Drug ineffective
  2. Immunodeficiency common variable
  3. Blood parathyroid hormone increased
  4. Constipation
  5. Depression
  6. Dizziness
  7. Duodenal ulcer
  8. Dyslipidaemia (abnormal amount of lipids)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Haematemesis (vomiting of blood)

What are the common drug interactions of Requip and Halcion, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Lipoma (a growth of fatty tissue that slowly develops just under your skin)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Migraine (headache)
  6. Mitral valve incompetence (inefficient heart valve)
  7. Mood disorder due to a general medical condition
  8. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  9. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  10. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

60+:

  1. Hallucination (an experience involving the perception of something not present)
  2. Arthralgia (joint pain)
  3. Pyelonephritis (inflammation of kidney caused by bacteria)
  4. Pyrexia (fever)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Anaemia (lack of blood)
  7. Blood parathyroid hormone increased
  8. Constipation
  9. Depression
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Parkinson's Disease: 8 people, 33.33%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 25.00%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 25.00%
  4. Stress And Anxiety: 3 people, 12.50%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 12.50%
  6. Spinal Osteoarthritis (joint cartilage loss in spine): 2 people, 8.33%
  7. Pain: 2 people, 8.33%
  8. Indigestion: 2 people, 8.33%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 8.33%
  10. Constipation: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Requip and Halcion?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Requip and Halcion:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Halcion:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Requip and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Halcion and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ropinirole hydrochloride and triazolam (the active ingredients of Requip and Halcion, respectively), and Requip and Halcion (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: